GE HealthCare Technologies Inc. (BMV:GEHC)
Mexico · Delayed Price · Currency is MXN 1,421.00
0.00 (0.00%)
At close: Jul 18, 2025, 2:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Product | 13.08B | Log In | Log In | Log In | Log In | Upgrade |
Product Growth | 0.81% | Log In | Log In | Log In | Log In | Upgrade |
Service | 6.60B | Log In | Log In | Log In | Log In | Upgrade |
Service Growth | 3.07% | Log In | Log In | Log In | Log In | Upgrade |
Patient Care Solutions (PCS) | 3.13B | Log In | Log In | Log In | Log In | Upgrade |
Patient Care Solutions (PCS) Growth | 0.74% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Diagnostics (PDx) | 2.51B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Diagnostics (PDx) Growth | 8.27% | Log In | Log In | Log In | Log In | Upgrade |
Other | 14.04B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 204.44% | Log In | Log In | Log In | Log In | Upgrade |
Imaging Revenue (Post-Q2 2024) | 8.86B | Log In | Log In | Log In | Log In | Upgrade |
Imaging Revenue (Post-Q2 2024) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Advanced Visualization Solutions (AVS) | 5.13B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Visualization Solutions (AVS) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Imaging | - | Log In | Log In | Log In | Log In | Upgrade |
Imaging Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ultrasound | - | Log In | Log In | Log In | Log In | Upgrade |
Ultrasound Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 14.04B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 204.44% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Other | 1.89B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 391.12% | Log In | Log In | Log In | Log In | Upgrade |
Patient Care Solutions (PCS) Segment EBIT | 347.00M | Log In | Log In | Log In | Log In | Upgrade |
Patient Care Solutions (PCS) Segment EBIT Growth | -11.55% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Diagnostics (PDx) Segment EBIT | 783.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth | 26.56% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment EBIT | 2.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Segment EBIT Growth | -37.50% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.89B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 391.12% | Log In | Log In | Log In | Log In | Upgrade |
Imaging EBIT (Post-Q2 2024) | 962.00M | Log In | Log In | Log In | Log In | Upgrade |
Imaging EBIT (Post-Q2 2024) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Advanced Visualization Solutions (AVS) EBIT | 1.12B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Visualization Solutions (AVS) EBIT Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Imaging Segment EBIT | - | Log In | Log In | Log In | Log In | Upgrade |
Imaging Segment EBIT Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ultrasound Segment EBIT | - | Log In | Log In | Log In | Log In | Upgrade |
Ultrasound Segment EBIT Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
USCAN | 8.98B | Log In | Log In | Log In | Log In | Upgrade |
USCAN Growth | 6.59% | Log In | Log In | Log In | Log In | Upgrade |
EMEA | 5.05B | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | -0.26% | Log In | Log In | Log In | Log In | Upgrade |
China | 2.36B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -13.06% | Log In | Log In | Log In | Log In | Upgrade |
Rest of World | 3.28B | Log In | Log In | Log In | Log In | Upgrade |
Rest of World Growth | 3.45% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Products Remaining Performance Obligations (RPO) | 4.76B | Log In | Log In | Log In | Log In | Upgrade |
Products Remaining Performance Obligations (RPO) Growth | -3.02% | Log In | Log In | Log In | Log In | Upgrade |
Services Remaining Performance Obligations (RPO) | 9.74B | Log In | Log In | Log In | Log In | Upgrade |
Services Remaining Performance Obligations (RPO) Growth | 7.42% | Log In | Log In | Log In | Log In | Upgrade |